BELLICUM PHARMACEUTICALS, INC Annual Interest Expense in USD from 2013 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Bellicum Pharmaceuticals, Inc quarterly/annual Interest Expense history and growth rate from 2013 to 2021.
  • Bellicum Pharmaceuticals, Inc Interest Expense for the quarter ending September 30, 2022 was $0.000.
  • Bellicum Pharmaceuticals, Inc Interest Expense for the twelve months ending September 30, 2022 was -$1K, a 101% decline year-over-year.
  • Bellicum Pharmaceuticals, Inc annual Interest Expense for 2021 was $4K, a 99.9% decline from 2020.
  • Bellicum Pharmaceuticals, Inc annual Interest Expense for 2020 was $2.66M, a 37.9% decline from 2019.
  • Bellicum Pharmaceuticals, Inc annual Interest Expense for 2019 was $4.28M, a 1.93% increase from 2018.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $4K -$2.66M -99.9% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-24
2020 $2.66M -$1.62M -37.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $4.28M +$81K +1.93% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $4.2M +$527K +14.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $3.67M +$1.91M +109% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
2016 $1.76M +$1.75M +14567% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-13
2015 $12K -$1.78M -99.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-13
2014 $1.79M +$1.74M +3412% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-13
2013 $51K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.